Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate

AIMS: To compare the pharmacokinetics of oseltamivir and oseltamivir carboxylate in hepatically impaired patients and healthy subjects. METHODS: Hepatically impaired patients (n = 11) and healthy subjects (n = 11) were individually paired on the basis of gender, age (±10 years) and body weight (±20%...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Snell, Paul, Dave, Nisha, Wilson, Katie, Rowell, Lucy, Weil, Angelica, Galitz, Lawrence, Robson, Richard
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Science Inc 2005
Materias:
Short Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884852/
https://ncbi.nlm.nih.gov/pubmed/15842560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02340.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares